Effect of administration of a synbiotic (Enterococcus faecium and agave inulin) on cognitive impairment in elderly adults

Natalia Rojas-Sánchez , Adela Escandón-Cesarman , Emilio Moreno-González , Oscar Mario Delgado-Casillas , Andrea P. Ibarra García , Ivan Ignacio-Mejía , Exsal Manuel Albores-Mendez , Marco Antonio Vargas-Hernandez , Martha Patricia Hernandez-Valdez , Paulina Romaña-Espiritu , Silvia G. Sanchez-Ávila , María E. Sanchez-Hernandez , Antonio Ibarra

Exploration of Neuroprotective Therapy ›› 2026, Vol. 6 ›› Issue (1) : 1004156

PDF (2243KB)
Exploration of Neuroprotective Therapy ›› 2026, Vol. 6 ›› Issue (1) :1004156 DOI: 10.37349/ent.2026.1004156
Original Article
research-article
Effect of administration of a synbiotic (Enterococcus faecium and agave inulin) on cognitive impairment in elderly adults
Author information +
History +
PDF (2243KB)

Abstract

Aim: To assess the effect of a synbiotic supplement composed of Enterococcus faecium and agave inulin on cognitive function in older adults with mild cognitive impairment (MCI). Methods: In a triple-blind randomized crossover trial, nineteen adults aged 64–85 years with MCI received either the synbiotic or an isocaloric vehicle for eight weeks, followed by a three-week washout and treatment crossover. Cognitive outcomes were assessed at baseline, after the first intervention, and after crossover using the Modified Mini-Mental State Examination (MMSE), Rey-Osterrieth Complex Figure Test (RCFT; copy and memory), and Abbreviated Instrument for Expectations of Self-Efficacy for Daily Activities in Older Adults (AERAC) self-efficacy scale. Paired and unpaired Student’s t-tests were used for statistical comparisons (p < 0.05). Results: The synbiotic group showed significant improvement relative to baseline across all domains: MMSE (p = 0.05), AERAC (p = 0.005), RCFT-copy (p = 0.03), and RCFT-memory (p = 0.03). Post-treatment comparisons between groups also favored the synbiotic, with significant differences in MMSE (p = 0.001), AERAC (p = 0.001), RCFT-copy (p = 0.0095), and RCFT-memory (p = 0.001). After crossover, cognitive gains were sustained and reproduced. MMSE scores reached 17.89 ± 1.45 in the synbiotic-first group versus 18.20 ± 0.63 in the control-first group (p < 0.001). RCFT-copy remained high (29.83 ± 4.18 vs. 29.52 ± 5.60, p = 0.0157), while RCFT-memory scores differed (17.56 ± 6.73 vs. 17.20 ± 3.29, p = 0.0005). AERAC scores continued to improve during crossover (82.60 ± 10.49 vs. 85.46 ± 8.28, p < 0.001). No adverse effects occurred. Conclusions: Synbiotic supplementation significantly improved global cognition, visuoconstructive ability, memory, and functional self-efficacy in older adults with MCI. Benefits persisted beyond the initial intervention and were replicated when the control group received the synbiotic, supporting its potential as a safe and effective strategy to mitigate age-related cognitive decline.

Keywords

aging / cognitive impairments / gut-brain axis / synbiotic supplementation

Cite this article

Download citation ▾
Natalia Rojas-Sánchez, Adela Escandón-Cesarman, Emilio Moreno-González, Oscar Mario Delgado-Casillas, Andrea P. Ibarra García, Ivan Ignacio-Mejía, Exsal Manuel Albores-Mendez, Marco Antonio Vargas-Hernandez, Martha Patricia Hernandez-Valdez, Paulina Romaña-Espiritu, Silvia G. Sanchez-Ávila, María E. Sanchez-Hernandez, Antonio Ibarra. Effect of administration of a synbiotic (Enterococcus faecium and agave inulin) on cognitive impairment in elderly adults. Exploration of Neuroprotective Therapy, 2026, 6 (1) : 1004156 DOI:10.37349/ent.2026.1004156

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Arriola Manchola E, Carnero Pardo C, Freire Pérez A, López Mongil R, López Trigo JA, Manzano Palomo S, et al. Deterioro cognitivo leve en el adulto mayor: documento de consenso [Internet]. Madrid: SOCIEDAD ESPAÑOLA DE GERIATRÍA Y GERONTOLOGÍA; c2017 [cited 2025 Dec 12]. Available from: https://www.segg.es/media/descargas/Consenso%20deteriorocognitivoleve.pdf

[2]

Romo-Araiza A, Ibarra A. Prebiotics and probiotics as potential therapy for cognitive impairment. Med Hypotheses. 2020; 134: 109410.

[3]

Borrás Blasco C, Viña Ribes J. Neurophysiology and ageing. Definition and pathophysiological foundations of cognitive impairment. Rev Esp Geriatr Gerontol. 2016; 51: 3-6. Spanish.

[4]

Benavides-Caro CA. Deterioro cognitivo en el adulto mayor. Rev Med. 2017; 40: 107-12.

[5]

Landefeld CS, editor. CURRENT Geriatric Diagnosis and Treatment. New York: McGraw-Hill Professional; 2004.

[6]

Mestre Navas JM, Cantero FP. Procesos psicológicos básicos: Una guía académica para los estudios en psicopedagogía, psicología y pedagogía. Madrid: McGraw-Hill; 2004.

[7]

Calabrese V, Santoro A, Monti D, Crupi R, Di Paola R, Latteri S, et al. Aging and Parkinson’s Disease: Inflammaging, neuroinflammation and biological remodeling as key factors in pathogenesis. Free Radic Biol Med. 2018; 115: 80-91.

[8]

United Nations. World Population Ageing 2023: Challenges and opportunities of population ageing in the least developed countries [Internet]. New York: United Nations; c2023 [cited 2026 Jan 6]. Available from: https://www.un.org/development/desa/pd/content/world-population-ageing-2023

[9]

Prince M, Jackson MJ, Ferri CP, Sousa R, Albanese E, Ribeiro WS, et al. World Alzheimer Report 2009. London: Alzheimer’s Disease International; 2009.

[10]

World Health Organization. Dementia [Internet]. Geneva: WHO; c2026 [cited 2026 Jan 15]. Available from: https://www.who.int/news-room/fact-sheets/detail/dementia

[11]

Reyna Carrizales MdL, González Rubio MV, López Esqueda FJ, González González GR. Demencias, una visión panorámica [Internet]. San Luis Potosí: UASLP; c2015 [cited 2025 Nov 24]. Available from: https://repositorioinstitucional.uaslp.mx/xmlui/handle/i/8979

[12]

Proyecciones de la población de México 2010-2050 [Internet]. México: CONSEJO NACIONAL DE POBLACIÓN; c2012 [cited 2025 Nov 22]. Available from: http://www.conapo.gob.mx/work/models/CONAPO/Resource/1529/2/images/DocumentoMetodologicoProyecciones2010_2050.pdf

[13]

Romo-Araiza A, Gutiérrez-Salmeán G, Galván EJ, Hernández-Frausto M, Herrera-López G, Romo-Parra H, et al. Probiotics and Prebiotics as a Therapeutic Strategy to Improve Memory in a Model of Middle-Aged Rats. Front Aging Neurosci. 2018; 10: 416.

[14]

Qian XH, Xie RY, Liu XL, Chen SD, Tang HD. Mechanisms of Short-Chain Fatty Acids Derived from Gut Microbiota in Alzheimer’s Disease. Aging Dis. 2022; 13: 1252-66.

[15]

Louzada ER, Ribeiro SML. Synbiotic supplementation, systemic inflammation, and symptoms of brain disorders in elders: A secondary study from a randomized clinical trial. Nutr Neurosci. 2020; 23: 93-100.

[16]

Silva YP, Bernardi A, Frozza RL. The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication. Front Endocrinol (Lausanne). 2020; 11: 25.

[17]

Westfall S, Lomis N, Kahouli I, Dia SY, Singh SP, Prakash S. Microbiome, probiotics and neurodegenerative diseases: deciphering the gut brain axis. Cell Mol Life Sci. 2017; 74: 3769-87.

[18]

González-Celis Rangel MA. Evaluación en psicogerontología [Internet]. México: El Manual Moderno; c2009 [cited 2025 Aug 15]. Available from: https://gc.scalahed.com/recursos/files/r161r/w25685w/Evaluacion%20en%20Psicogerontologia.pdf

[19]

Novotný M, Klimova B, Valis M. Microbiome and Cognitive Impairment: Can Any Diets Influence Learning Processes in a Positive Way? Front Aging Neurosci. 2019; 11: 170.

[20]

Dalile B, Verbeke K, Van Oudenhove L, Vervliet B. Nourishing the gut microbiota: The potential of prebiotics in microbiota-gut-brain axis research. Behav Brain Sci. 2019; 42: e69.

[21]

Mörkl S, Butler MI, Holl A, Cryan JF, Dinan TG. Probiotics and the Microbiota-Gut-Brain Axis: Focus on Psychiatry. Curr Nutr Rep. 2020; 9: 171-82.

[22]

O’Toole PW, Jeffery IB. Gut microbiota and aging. Science. 2015; 350: 1214-5.

[23]

Ticinesi A, Tana C, Nouvenne A, Prati B, Lauretani F, Meschi T. Gut microbiota, cognitive frailty and dementia in older individuals: a systematic review. Clin Interv Aging. 2018; 13: 1497-511.

[24]

Carabotti M, Scirocco A, Maselli MA, Severi C. The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems. Ann Gastroenterol. 2015; 28: 203-9.

[25]

Vandeputte D, Falony G, Vieira-Silva S, Wang J, Sailer M, Theis S, et al. Prebiotic inulin-type fructans induce specific changes in the human gut microbiota. Gut. 2017; 66: 1968-74.

[26]

Olveira G, González-Molero I. An update on probiotics, prebiotics and symbiotics in clinical nutrition. Endocrinol Nutr. 2016; 63: 482-94.

[27]

Sharma D, Saharan BS, Chauhan N, Procha S, Lal S. Isolation and functional characterization of novel biosurfactant produced by Enterococcus faecium. Springerplus. 2015; 4: 4.

[28]

Gibson GR, Hutkins R, Sanders ME, Prescott SL, Reimer RA, Salminen SJ, et al. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat Rev Gastroenterol Hepatol. 2017; 14: 491-502.

[29]

Hanchi H, Mottawea W, Sebei K, Hammami R. The Genus Enterococcus: Between Probiotic Potential and Safety Concerns-An Update. Front Microbiol. 2018; 9: 1791.

[30]

Shi Y, Zhai M, Li J, Li B. Evaluation of safety and probiotic properties of a strain of Enterococcus faecium isolated from chicken bile. J Food Sci Technol. 2020; 57: 578-87.

[31]

Ferrarese R, Ceresola ER, Preti A, Canducci F. Probiotics, prebiotics and synbiotics for weight loss and metabolic syndrome in the microbiome era. Eur Rev Med Pharmacol Sci. 2018; 22: 7588-605.

[32]

Clarke G, Stilling RM, Kennedy PJ, Stanton C, Cryan JF, Dinan TG. Minireview: Gut microbiota: the neglected endocrine organ. Mol Endocrinol. 2014; 28: 1221-38.

[33]

Bautista-Justo M, García-Oropeza L, Salcedo-Hernández R, Parra-Negrete LA. Azúcares en agaves (Agave tequilana Weber) cultivados en el Estado de Guanajuato. Acta Univ. 2001; 11: 33-8. Spanish.

[34]

Rogers GB, Keating DJ, Young RL, Wong ML, Licinio J, Wesselingh S. From gut dysbiosis to altered brain function and mental illness: mechanisms and pathways. Mol Psychiatry. 2016; 21: 738-48.

[35]

Holzapfel W, Arini A, Aeschbacher M, Coppolecchia R, Pot B. Enterococcus faecium SF68 as a model for efficacy and safety evaluation of pharmaceutical probiotics. Benef Microbes. 2018; 9: 375-88.

[36]

Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12: 189-98.

[37]

George PP, Lun P, Ong SP, Lim WS. A Rapid Review of the Measurement of Intrinsic Capacity in Older Adults. J Nutr Health Aging. 2021; 25: 774-82.

[38]

Shin MS, Park SY, Park SR, Seol SH, Kwon JS. Clinical and empirical applications of the Rey-Osterrieth Complex Figure Test. Nat Protoc. 2006; 1: 892-9.

[39]

Meyers JE, Meyers KR. Rey Complex Figure Test and Recognition Trial: Professional Manual. Odessa, FL: Psychological Assessment Resources; 1995.

[40]

Kim CS, Cha L, Sim M, Jung S, Chun WY, Baik HW, et al. Probiotic Supplementation Improves Cognitive Function and Mood with Changes in Gut Microbiota in Community-Dwelling Older Adults: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial. J Gerontol A Biol Sci Med Sci. 2021; 76: 32-40.

[41]

Pinilla FJ, Martínez-Tomás R, Rincón M. Automatic Scoring of Rey-Osterrieth Complex Figure Test Using Recursive Cortical Networks. In: Ferrández Vicente JM, Álvarez-Sánchez JR, de la Paz López F, Adeli H, editors. Artificial Intelligence in Neuroscience: Affective Analysis and Health Applications. Cham: Springer; 2022. pp. 455-63.

[42]

Zhang X, Lv L, Min G, Wang Q, Zhao Y, Li Y. Overview of the Complex Figure Test and Its Clinical Application in Neuropsychiatric Disorders, Including Copying and Recall. Front Neurol. 2021; 12: 680474.

[43]

Dalile B, Van Oudenhove L, Vervliet B, Verbeke K. The role of short-chain fatty acids in microbiota-gut-brain communication. Nat Rev Gastroenterol Hepatol. 2019; 16: 461-78.

[44]

Dinan TG, Stilling RM, Stanton C, Cryan JF. Collective unconscious: how gut microbes shape human behavior. J Psychiatr Res. 2015; 63: 1-9.

[45]

Molinari C, Morsanuto V, Ruga S, Notte F, Farghali M, Galla R, et al. The Role of BDNF on Aging-Modulation Markers. Brain Sci. 2020; 10: 285.

[46]

Martins IJ. Anti-Aging Genes Improve Appetite Regulation and Reverse Cell Senescence and Apoptosis in Global Populations. Adv Aging Res. 2016; 5: 9-26.

[47]

Gao J, Wang WY, Mao YW, Gräff J, Guan JS, Pan L, et al. A novel pathway regulates memory and plasticity via SIRT1 and miR-134. Nature. 2010; 466: 1105-9.

[48]

Michán S, Li Y, Chou MM, Parrella E, Ge H, Long JM, et al. SIRT1 is essential for normal cognitive function and synaptic plasticity. J Neurosci. 2010; 30: 9695-707.

[49]

Herskovits AZ, Guarente L. SIRT1 in neurodevelopment and brain senescence. Neuron. 2014; 81: 471-83.

[50]

Borre YE, O’Keeffe GW, Clarke G, Stanton C, Dinan TG, Cryan JF. Microbiota and neurodevelopmental windows: implications for brain disorders. Trends Mol Med. 2014; 20: 509-18.

[51]

Arias CA, Murray BE. The rise of the Enterococcus: beyond vancomycin resistance. Nat Rev Microbiol. 2012; 10: 266-78.

[52]

Calderón-Jaimes E, Arredondo-García JL, Aguilar-Ituarte F, García-Roca P. In vitro antimicrobial susceptibility in clinical isolates of Enterococcus species. Salud Publica Mex. 2003; 45: 96-101.

[53]

Abriouel H, Ben Omar N, Lucas López R, Gálvez A. LA DOBLE FACETA DEL GéNERO EntErococcus, Y SU IMPORTANCIA EN ALIMENTOS. An Real Acad Cienc Vet Andal Orient. 2008; 21: 65-84.

[54]

Canani RB, Cirillo P, Terrin G, Cesarano L, Spagnuolo MI, De Vincenzo A, et al. Probiotics for treatment of acute diarrhoea in children: randomised clinical trial of five different preparations. BMJ. 2007; 335: 340.

PDF (2243KB)

0

Accesses

0

Citation

Detail

Sections
Recommended

/

〈 〉